MRZM insider filings
MARIZYME, INC. — 17 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-12-28. Screen MRZM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for MRZM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — MARIZYME, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-12-28 | 4 | Braeden Lichti — 10% owner | Conversion (C): 3,815,294 @ $0.10 · Conversion (C): 2 (derivative) @ $0 | EDGAR |
| 2023-09-08 | 4/A | Lichti Braeden — 10% owner | Sale (S): 106,327 @ $0.09 · Sale (S): 97,000 @ $0.10 · Sale (S): 105,000 @ $0.17 | EDGAR |
| 2023-09-07 | 4 | Lichti Braeden — 10% owner | Purchase (P): 106,327 @ $0.09 · Purchase (P): 97,000 @ $0.10 · Purchase (P): 105,000 @ $0.17 | EDGAR |
| 2023-04-20 | 4 | Dhaduk Vithalbhai D — Chairman of the Board, Director, 10% owner | Grant/award (A): 1,063,938 @ $0.10 · Disposition to issuer (D): 1,063,938 (derivative) @ $0 · Grant/award (A): 1,063,938 (derivative) @ $0 · Disposition to issuer (D): 1,063,938 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Brostowin Terry A — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Hearl William — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Dhaduk Vithalbhai D — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Patel Nilesh Umedbhai — Director | Holdings only — no transactions reported | EDGAR |
| 2022-06-09 | 4 | Kampf Julie B. — Director | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | STEWART MICHAEL R — Director | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2022-06-07 | 4 | Hearl William — Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2022-03-21 | 4 | Ross Harrison — Vice President of Finance | Grant/award (A): 273,750 (derivative) @ $0.09 | EDGAR |
| 2022-03-18 | 4 | Kovalyov Georgiy — Chief Financial Officer | Grant/award (A): 273,750 (derivative) @ $0.09 | EDGAR |
| 2022-02-09 | 4 | Barthel David — Chief Executive Officer, Director | Disposition to issuer (D): 400,000 (derivative) · Grant/award (A): 400,000 (derivative) | EDGAR |
| 2021-03-31 | 4 | Brostowin Terry A — Director | Grant/award (A): 125,000 (derivative) @ $1.25 | EDGAR |
| 2021-03-23 | 4 | SAPIRSTEIN JAMES — Interim CEO, Director | Grant/award (A): 125,000 (derivative) @ $1.25 | EDGAR |
| 2020-11-16 | 4 | Harmon Bruce — CFO | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — MARIZYME, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-04-17 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.03 — Bankruptcy or Receivership 2.01 — Completion of Acquisition or Disposition of Assets 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-03-04 | 8-K | 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | EDGAR |
| 2025-01-31 | 8-K | 4.02 — Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review | EDGAR |
| 2024-07-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-05-06 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2024-02-06 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2023-12-28 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-11-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-24 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2023-10-23 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MRZM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs